ABOS Stock Analysis: Buy, Sell, or Hold?
ABOS - Acumen Pharmaceuticals, Inc. Common Stock
$2.60
-0.19 (-6.81%)
▼
WAIT
LOW Confidence
Last Updated: January 30, 2026
Earnings: Mar 26, 2026
Get Alerted When ABOS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called ABOS this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: ABOS is 11.1% above fair value ($2.34). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: ABOS is 11.1% above fair value ($2.34). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: ABOS is currently trading at $2.60, which is considered extended relative to its 30-day fair value range of $1.77 to $2.34.
Technical Outlook: Technically, ABOS is in a uptrend. Immediate support is located at $1.76, while resistance sits at $3.05. Short-term momentum is weak, with the stock down 6.8% recently.
Market Sentiment: ABOS has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $7.00 (+169.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ABOS is in a uptrend. Immediate support is located at $1.76, while resistance sits at $3.05. Short-term momentum is weak, with the stock down 6.8% recently.
Market Sentiment: ABOS has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $7.00 (+169.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$1.77 -
$2.34
Company Quality Score
63/100
(BUY)
Volume Confirmation
MODERATE
Confidence Score
42.1%
Protect Your Profits
Holding ABOS? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price significantly overextended (+11.1% above fair value)
- BULLISH: Strong technical setup (75/100)
- BEARISH: Downward momentum (-6.8%)
- BULLISH: Trading 169.2% below Wall St target ($7.00)
Fair Price Analysis
30-Day Fair Range
$1.77 -
$2.34
Current vs Fair Value
EXTENDED
Support & Resistance Levels
Support Level
$1.76
Resistance Level
$3.05
Current Trend
Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-1.50
Wall Street Target
$7.00
(+169.2%)
Last updated: February 01, 2026 1:04 PM ET
Data refreshes hourly during market hours. Next update: 2:04 PM
Data refreshes hourly during market hours. Next update: 2:04 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ABOS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
33 analysts |
$477 | 45 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
19 analysts |
$215 | 60 BUY |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$93 | 56 HOLD |
|
ASND
Ascendis Pharma AS |
STRONG BUY
16 analysts |
$277 | 59 HOLD |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$19 | 55 HOLD |
Advanced ABOS Option Strategies
Professional options setups generated by AI based on today's ABOS price and gamma walls.
